HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Correspondence: Submit a response Alert me when this article is cited Alert me when Correspondence are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Raes, I. Articles by Lehrer, G. M. Search for Related Content PubMed PubMed Citation Articles by Raes, I. Articles by Lehrer, G. M.

2', 3'-cyclic nucleotide 3' -phosphodiesterase in cerebrospinal fluid

Department of Neurology (Drs. Raes, Weissbarth, Maker, and Lehrer), Mount Sinai School of Medicine. CUNY, New York, NY, and the Department of Neurology (Drs. Maker and Lehrer), Bronx Veterans Administration Hospital, Bronx, NY.

The activity of the myelin-associated enzyme 2', 3'-cyclic nucleotide 3'-phosphodiesterase (CNP) was assayed in the cerebrospinal fluid (CSF) of 107 neurologic patients by a new and sensitive fluorometric method. The activity of CNP was about 20 nmol per hour per milligram protein or 12 nmol per hour per milliliter CSF. At these extremely low levels, the presence of even a small amount of blood (which has slightly greater activity) significantly elevated CNP values. Patients with radicular syndromes had slightly higher than average CNP activities, but there was no difference in enzyme activities of 47 patients with multiple sclerosis and the general neurologic population. CNP activity was not related to stage of demyelinating illness or intrathecal injection of steroid. CNP-like myelin basic protein may be released into the CSF after destruction of myelin, but our results suggest that the enzyme activity is lost in the process.

Address correspondence and reprint requests to Dr. Maker, Mount Sinai Hospital. 1 Gustave Levy Place, New York, NY 10029.

Accepted for publication January 6, 1981

Supported by the Belgian-American Educational Foundation. Inc., and in part by NIH Grants No. NS-15771 and No. NS-11631 (Clinical Research Center for the study of Parkinson's and Allied Diseases).